BIVI News and Press, BioVie Inc. From 11/29/23

2023-11-29 10:00:03 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector a...

Positive Trending Data from 57 Per-Protocol Patients Suggest NE3107 is Biologically Active and May Have Impact on Cognitive, Functional, and Biomarker Endpoints Sponsor Identified Issues Relating to Significant GCP Violations and Protocol Deviations, Which Allowed for Data from Only a...

2023-11-22 20:12:00 ET Summary Blinded Phase 3 data of NE3107 in Alzheimer's appear to indicate robust cognitive and biomarker efficacy. Market is significantly undervaluing the probability of a successful data unblinding expected shortly after Thanksgiving. Potential to be th...

2023-11-22 12:41:46 ET More on Mid-day movers stock. BioVie: Upcoming Phase 3 Readout In Alzheimer's May Create Significant Value BioVie: Bullish Signals From Blinded Data Presentation (Rating Upgrade) BioVie: Well-Powered Phase 3 Trial In Alzheimer's Could Greatly B...

2023-11-22 12:37:58 ET DENVER, Colo., Nov. 22, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; SciSparc Ltd (NASDAQ: SPRC), PaxMedica Inc (NASDAQ: PXMD), MoneyHero Ltd (NASDAQ: MNY), Jumia Technolo...

2023-11-16 10:00:07 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: XWELL, Xeris B...

2023-11-16 08:32:33 ET WaveDancer  ( WAVD ) +108% Announces Merger Agreement with Firefly Neuroscience. HNR Acquisition  ( HNRA ) +19% Announces Completion of its Business Combination by Acquisition of Pogo Resources, LLC; HNRA begins Managing and Operating...

2023-11-15 18:54:16 ET Summary BioVie is set to report topline data from its Phase 3 trial in Alzheimer's disease, with a high likelihood of reaching statistical significance. Blinded data from the trial showed a reduction in amyloid burden and cognitive improvements in about 75% ...

Data Show that BIV201 in Combination with Standard of Care (SOC) is Well Tolerated with No Major Difference in Treatment-Emergent Adverse Events (TEAEs) Compared to SOC Alone With a ~50% Mortality Rate for Refractory Patients 1 , Efficacy and Safety Findings from the Phase 2...

HST Global Inc (HSTC) is expected to report for quarter end 2023-09-30 Air China Ltd ADR - Level I (AIRYY) is expected to report for Q3 2023 GrafTech International Ltd. (EAF) is expected to report $-0.05 for Q3 2023 Cardinal Health Inc. (CAH) is expected to report $1.4 for Q1 2024 ...